Malaria
What's New
Last Posted: Aug 04, 2022
- Monoclonal antibodies for malaria prevention.
Aleshnick Maya et al. Molecular therapy : the journal of the American Society of Gene Therapy 2022 4 (5) 1810-1821 - Distribution of HbS Allele and Haplotypes in a Multi-Ethnic Population of Guinea Bissau, West Africa: Implications for Public Health Screening.
Martella Maddalena et al. Frontiers in pediatrics 2022 10826262 - DNA testing for sickle cell anemia in Africa: Implementation choices for the Democratic Republic of Congo.
Ngole Mamy et al. Journal of clinical laboratory analysis 2022 e24398 - Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning.
Das Debashish et al. Malaria journal 2022 21(1) 122 - Predicting the impact of climate change on the re-emergence of malaria cases in China using LSTMSeq2Seq deep learning model: a modelling and prediction analysis study.
Kamana Eric et al. BMJ open 2022 12(3) e053922 - An Empirical Evaluation of Convolutional Networks for Malaria Diagnosis.
Loddo Andrea et al. Journal of imaging 2022 8(3) - An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria.
Pernaute-Lau Leyre et al. Expert opinion on drug metabolism & toxicology 2022 - Identification of novel genetic variants in the malaria vaccine candidate PfRh5: structure-guided insights into potential function
K Mangou et al, MEDRXIV, March 20, 2022 - Evaluation of an accelerometer-based monitor for detecting bed net use and human entry/exit using a machine learning algorithm.
Koudou Guibehi B et al. Malaria journal 2022 21(1) 85 - Development and Validation of Manually Modified and Supervised Machine Learning Clinical Assessment Algorithms for Malaria in Nigerian Children.
McLaughlin Megan et al. Frontiers in artificial intelligence 2022 4554017
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
- CDC Information (11)
- NIH Information (5)
- COVID-19 (92)
- CDC Publications (133)
- Human Genome Epidemiologic Studies (575)
- GWAS Studies (16)
- Human Genomics Translation/Implementation Studies (32)
- Genomic Tests Evidence Synthesis (4)
- Non-Genomics Precision Health (25)
- Pathogen Advanced Molecular Detection (410)
- Reviews/Commentaries (31)
- Tools/Methods (1)
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Jul 25, 2022
- Page last updated:Dec 03, 2022
- Content source: